Xiaoteng Cui

1.6k citations

40 papers · 932 indexed · h-index 19

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Genetics top 10%
- Glioma Diagnosis and Treatment

Papers in ⓘ

Molecular Biology 22
- RNA Research and Splicing 5
- Extracellular vesicles in disease 5
- RNA modifications and cancer 5
Cancer Research 18
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 5

Co-authors: Chunsheng Kang (23 shared papers)Qixue Wang (18 shared papers)Yanli Tan (11 shared papers)Jie Yang (13 shared papers)Chuan Fang (10 shared papers)Xingjie Gao (13 shared papers)Yunfei Wang (11 shared papers)Kaikai Yi (8 shared papers)
Journals: Neuro-Oncology (5 papers)Theranostics (4 papers)Cell Death and Disease (2 papers)Cancer Biology and Medicine (2 papers)FEBS Journal (2 papers)
Partner nations: China Canada Montenegro

In The Last Decade

Xiaoteng Cui

38 papers receiving 931 citations

Peers

Countries citing papers authored by Xiaoteng Cui

Since Specialization

Citations

This map shows the geographic impact of Xiaoteng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoteng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoteng Cui more than expected).

Fields of papers citing papers by Xiaoteng Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoteng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoteng Cui. The network helps show where Xiaoteng Cui may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoteng Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoteng Cui Line = papers co-authored together Xiaoteng Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors Genomics ·Xiaoteng Cui, Xinxin Zhang, Minghui Liu, Chunyan Zhao, Nan Zhang, Yuanyuan Ren, Chao Su, Wei Zhang, Xiaoming Sun, Jinyan He, Xingjie Gao, Jie Yang	2020	111
2	Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy Neuro-Oncology ·Qi Zhan, Kaikai Yi, Xiaoteng Cui, Xueping Li, Shixue Yang, Qixue Wang, Chuan Fang, Yanli Tan, Lijie Li, Can Xu, Xubo Yuan, Chunsheng Kang	2022	87
3	RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner Cell Death and Disease ·Kai Zhao, Xiaoteng Cui, Qixue Wang, Chuan Fang, Yanli Tan, Yunfei Wang, Kaikai Yi, Chao Yang, Hua You, Rui Shang, Jiachong Wang, Chunsheng Kang	2019	52
4	Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery Macromolecular Bioscience ·Qi Zhan, Kaikai Yi, Xueping Li, Xiaoteng Cui, Eryan Yang, Ning Chen, Xubo Yuan, Jin Zhao, Xin Hou, Chunsheng Kang	2021	50
5	LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis Theranostics ·Yansheng Li, Xing Liu, Xiaoteng Cui, Yanli Tan, Qixue Wang, Yunfei Wang, Can Xu, Chuan Fang, Chunsheng Kang	2021	45
6	A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma Neuro-Oncology ·Jixing Zhao, Shixue Yang, Xiaoteng Cui, Qixue Wang, Eryan Yang, Fei Tong, Biao Hong, Menglin Xiao, Xin Lei, Can Xu, Yanli Tan, Chunsheng Kang	2022	43
7	SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma RNA Biology ·Xiaoteng Cui, Chunyan Zhao, Xuyang Yao, Baoxin Qian, Chao Su, Yuanyuan Ren, Zhi Yao, Xingjie Gao, Jie Yang	2018	42
8	TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma Theranostics ·Shixue Yang, Jixing Zhao, Xiaoteng Cui, Qi Zhan, Kaikai Yi, Qixue Wang, Menglin Xiao, Yanli Tan, Biao Hong, Chuan Fang, Chunsheng Kang	2022	36
9	Poly(A)⁺ mRNA‐binding protein Tudor‐SN regulates stress granules aggregation dynamics FEBS Journal ·Xingjie Gao, Xue Fu, Juan Song, Yi Zhang, Xiaoteng Cui, Chao Su, Lin Ge, Jie Shao, Lingbiao Xin, Juha Saarikettu, Mei Mei, Xi Yang, Minxin Wei, Olli Silvennoinen, Zhi Yao, Jinyan He, Jie Yang	2015	36
10	Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8 ⁺ T cell response in tumor Science Advances ·Yuan Wang, Xinting Wang, Xiaoteng Cui, Yue Zhuo, Hongshuai Li, Chuanbo Ha, Lingbiao Xin, Yuanyuan Ren, Wei Zhang, Xiaoming Sun, Lin Ge, Xin Liu, Jinyan He, Tao Zhang, Kai Zhang, Zhi Yao, Xi Yang, Jie Yang	2020	33
11	Phosphorylation of Tudor-SN, a novel substrate of JNK, is involved in the efficient recruitment of Tudor-SN into stress granules Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Chao Su, Xingjie Gao, Wendong Yang, Yali Zhao, Xue Fu, Xiaoteng Cui, Chunyan Zhang, Lingbiao Xin, Yuanyuan Ren, Lixin Li, Wenqing Shui, Xi Yang, Minxin Wei, Jie Yang	2016	32
12	PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma Theranostics ·Eryan Yang, Lin Wang, Weili Jin, Xing Liu, Qixue Wang, Ye Wu, Yanli Tan, Yunfei Wang, Xiaoteng Cui, Jixing Zhao, Fei Tong, Biao Hong, Menglin Xiao, Xiaomin Liu, Chuan Fang, Chunsheng Kang	2022	27
13	PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma Frontiers in Immunology ·Kaikai Yi, Xiaoteng Cui, Xing Liu, Yunfei Wang, Jixing Zhao, Shixue Yang, Can Xu, Eryan Yang, Menglin Xiao, Biao Hong, Chuan Fang, Chunsheng Kang, Yanli Tan, Qixue Wang	2022	26
14	Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage Frontiers in Oncology ·Xiaoteng Cui, Qixue Wang, Junhu Zhou, Yunfei Wang, Can Xu, Fei Tong, Hongjun Wang, Chunsheng Kang	2021	25
15	MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII Pharmacological Research ·Fei Tong, Jixing Zhao, Zi-yuan Fang, Xiaoteng Cui, Dong-yuan Su, Xing Liu, Junhu Zhou, Guangxiu Wang, Zhi‐Jun Qiu, Shizhong Liu, Junqi Fu, Chunsheng Kang, Jiachong Wang, Qixue Wang	2022	25
16	HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma Neuro-Oncology ·Shixue Yang, Qi Zhan, Dongyuan Su, Xiaoteng Cui, Jixing Zhao, Qixue Wang, Biao Hong, Jiasheng Ju, Chunchao Cheng, Eryan Yang, Chunsheng Kang	2024	24
17	Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma Cancer Communications ·Xiaoteng Cui, Jixing Zhao, Guanzhang Li, Chao Yang, Shixue Yang, Qi Zhan, Junhu Zhou, Yunfei Wang, Menglin Xiao, Biao Hong, Kaikai Yi, Fei Tong, Yanli Tan, Hu Wang, Qixue Wang, Tao Jiang, Chuan Fang, Chunsheng Kang	2023	22
18	CRISPR-Cas9 library screening combined with an exosome-targeted delivery system addresses tumorigenesis/TMZ resistance in the mesenchymal subtype of glioblastoma Theranostics ·Jixing Zhao, Xiaoteng Cui, Zhan Qi, Kailiang Zhang, Dongyuan Su, Shixue Yang, Biao Hong, Qixue Wang, Jiasheng Ju, Chunchao Cheng, Chen Li, Chunxiao Wan, Yunfei Wang, Junhu Zhou, Chunsheng Kang	2024	21
19	Growth arrest–specific 2 protein family: Structure and function Cell Proliferation ·Nan Zhang, Chunyan Zhao, Xinxin Zhang, Xiaoteng Cui, Yan Zhao, Jie Yang, Xingjie Gao	2020	21
20	The effects of tumor necrosis factor-α (TNF-α) rs1800629 and rs361525 polymorphisms on sepsis risk Oncotarget ·Yixin Zhang, Xiaoteng Cui, Ning Li, Dianjun Wei	2017	17

About Xiaoteng Cui

Xiaoteng Cui is a scholar working on Molecular Biology, Cancer Research, Immunology, Pathology and Forensic Medicine and Genetics, having authored 40 papers that have together received 932 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (11 papers), Glioma Diagnosis and Treatment (10 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers), Ferroptosis and cancer prognosis (5 papers), RNA Research and Splicing (5 papers), Extracellular vesicles in disease (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (386 citations), Genetics (142 citations), Molecular Biology (611 citations), Immunology (135 citations) and Pathology and Forensic Medicine (106 citations). Xiaoteng Cui has collaborated with scholars based in China, Canada and Montenegro. Frequent co-authors include Chunsheng Kang, Qixue Wang, Yanli Tan, Jie Yang, Chuan Fang, Xingjie Gao, Yunfei Wang, Kaikai Yi, Shixue Yang and Can Xu. Their work appears in journals such as Neuro-Oncology, Theranostics, Cell Death and Disease, Cancer Biology and Medicine and FEBS Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact